BR9700957A - Proteína de hormónio de crescimento humano mutante deoxiribonucleotídeo peptídeo de uma proteína plasmídeo de expressão produto anticorpo medicamentos para o tratamento de gigantismo e acromegalia e para terapia genética - Google Patents

Proteína de hormónio de crescimento humano mutante deoxiribonucleotídeo peptídeo de uma proteína plasmídeo de expressão produto anticorpo medicamentos para o tratamento de gigantismo e acromegalia e para terapia genética

Info

Publication number
BR9700957A
BR9700957A BR9700957A BR9700957A BR9700957A BR 9700957 A BR9700957 A BR 9700957A BR 9700957 A BR9700957 A BR 9700957A BR 9700957 A BR9700957 A BR 9700957A BR 9700957 A BR9700957 A BR 9700957A
Authority
BR
Brazil
Prior art keywords
growth hormone
gigantism
acromegaly
treatment
protein
Prior art date
Application number
BR9700957A
Other languages
English (en)
Inventor
Kazuo Chihara
Original Assignee
Japan Chem Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26391431&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9700957(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Japan Chem Res filed Critical Japan Chem Res
Publication of BR9700957A publication Critical patent/BR9700957A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/12—Growth hormone, growth factor other than t-cell or b-cell growth factor, and growth hormone releasing factor; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Farming Of Fish And Shellfish (AREA)
  • Physical Deposition Of Substances That Are Components Of Semiconductor Devices (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BR9700957A 1996-02-13 1997-02-13 Proteína de hormónio de crescimento humano mutante deoxiribonucleotídeo peptídeo de uma proteína plasmídeo de expressão produto anticorpo medicamentos para o tratamento de gigantismo e acromegalia e para terapia genética BR9700957A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP5094096 1996-02-13
JP17864396 1996-06-18

Publications (1)

Publication Number Publication Date
BR9700957A true BR9700957A (pt) 1998-12-08

Family

ID=26391431

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9700957A BR9700957A (pt) 1996-02-13 1997-02-13 Proteína de hormónio de crescimento humano mutante deoxiribonucleotídeo peptídeo de uma proteína plasmídeo de expressão produto anticorpo medicamentos para o tratamento de gigantismo e acromegalia e para terapia genética

Country Status (8)

Country Link
US (1) US6238915B1 (pt)
EP (1) EP0790305B1 (pt)
KR (1) KR980002066A (pt)
AT (1) ATE216723T1 (pt)
AU (1) AU723494B2 (pt)
BR (1) BR9700957A (pt)
CA (1) CA2197408A1 (pt)
DE (1) DE69712124T2 (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0397834B1 (en) 1988-10-28 2000-02-02 Genentech, Inc. Method for identifying active domains and amino acid residues in polypeptides and hormone variants
US6780613B1 (en) 1988-10-28 2004-08-24 Genentech, Inc. Growth hormone variants
JP3417558B2 (ja) 1991-05-10 2003-06-16 ジェネンテク，インコーポレイテッド 配位子作用薬および拮抗薬の選択
US6506595B2 (en) * 1998-03-31 2003-01-14 Itoham Foods Inc. DNAs encoding new fusion proteins and processes for preparing useful polypeptides through expression of the DNAs
GB0011459D0 (en) * 2000-05-12 2000-06-28 Univ Wales Medicine Sequences
BR0110756A (pt) * 2000-05-12 2003-07-08 Univ Wales Medicine Método de detecção para detectar uma variação em gh1 efetiva para atuar como um indicador de disfunção de gh em um indivìduo, variante de gh1, proteìna ou sequência de aminoácidos, variante de gh humano, método de triagem para triar um indivìduo suspeito de ter disfunção de gh, kit, sequência de ácido nucleico isolada, purificada ou recombinante, vetor, célula hospedeira, processo para preparar uma variante de gh, sequência de aminoácidos, composição, e, uso de variante de gh1 ou uma variante de gh
US20030170679A1 (en) * 2001-11-09 2003-09-11 Wood Linda Susan Single nucleotide polymorphisms in GH-1
GB0127213D0 (en) * 2001-11-12 2002-01-02 Univ Wales Medicine Method of detecting growth hormone variations in humans the variations and their uses
GB2389115B (en) * 2001-12-14 2005-03-16 Asterion Ltd Polypeptide having a plurality of modified growth hormone receptor binding domains of growth hormone
DE60332358D1 (de) * 2002-09-09 2010-06-10 Hanall Pharmaceutical Co Ltd Protease-resistente modifizierte interferon alpha polypeptide
GB0229725D0 (en) * 2002-12-19 2003-01-29 Univ Wales Medicine Haplotype partitioning and growth hormone SNPs
SE0300959D0 (sv) * 2002-12-19 2003-04-02 Pharmacia Ab Methods for predicting therapeutic response to agents acting on the growth hormone receptor
NZ525314A (en) * 2002-12-19 2005-02-25 Univ Cardiff Method and kit for diagnosing growth hormone dysfunction by determining SNP haplotypes of the proximal promoter region of the gene GH1
US7998930B2 (en) 2004-11-04 2011-08-16 Hanall Biopharma Co., Ltd. Modified growth hormones
US20070154992A1 (en) 2005-04-08 2007-07-05 Neose Technologies, Inc. Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants
EP2446898A1 (en) 2010-09-30 2012-05-02 Laboratorios Del. Dr. Esteve, S.A. Use of growth hormone to enhance the immune response in immunosuppressed patients
CN112399851A (zh) 2018-07-11 2021-02-23 俄亥俄大学 基于肽的生长激素作用抑制剂及其使用方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BG49718A3 (bg) * 1983-07-15 1992-01-15 Bio- Technology General Corp Метод за получаване на полипептид със супероксиддисмутазна активност
US5534617A (en) * 1988-10-28 1996-07-09 Genentech, Inc. Human growth hormone variants having greater affinity for human growth hormone receptor at site 1
EP0397834B1 (en) * 1988-10-28 2000-02-02 Genentech, Inc. Method for identifying active domains and amino acid residues in polypeptides and hormone variants
US5350836A (en) * 1989-10-12 1994-09-27 Ohio University Growth hormone antagonists
FI934829A0 (fi) 1991-05-01 1993-11-01 Univ Ohio Antagonister foer tillvaexthormon

Also Published As

Publication number Publication date
CA2197408A1 (en) 1997-08-14
DE69712124T2 (de) 2002-12-12
AU723494B2 (en) 2000-08-31
ATE216723T1 (de) 2002-05-15
AU1266497A (en) 1997-08-21
EP0790305A1 (en) 1997-08-20
US6238915B1 (en) 2001-05-29
EP0790305B1 (en) 2002-04-24
DE69712124D1 (de) 2002-05-29
KR980002066A (ko) 1998-03-30

Similar Documents

Publication Publication Date Title
BR9700957A (pt) Proteína de hormónio de crescimento humano mutante deoxiribonucleotídeo peptídeo de uma proteína plasmídeo de expressão produto anticorpo medicamentos para o tratamento de gigantismo e acromegalia e para terapia genética
EP1114863A3 (en) Heregulins (HRGs), binding proteins of P185erb2
DE68929043D1 (de) Für androgen-rezeptor-protein kodierende dna
WO1993023434A3 (en) Bpi-immunoglobulin fusion proteins
DE69334266D1 (de) Therapeutische Zusammensetzungen aus Antikorper und Antisens Nukleinsäuren gegen Serrate
PT93910A (pt) Prodesso para a preparacao de uma proteina heterologa mediante secrecao a partir de uma celula
EP0617126A3 (en) Polypeptide capable of inhibiting the binding between human IL-6 and its receptor.
ATE365744T1 (de) Nukleinsäuremoleküle, proteine und peptide, die im zusammenhang stehen mit dickdarmzellen und dickdarm-krebszellen
AU3498189A (en) Fibronectin binding protein
HUP9902429A2 (hu) TNF-receptor-asszociált faktor (TRAF) modulátorok előállítása és alkalmazása
ATE307886T1 (de) Nukleotidsequenzen, proteine, medikamente und diagnoseagentien zur anwendung in krebsbehandlung
DE3853446D1 (de) Fibronectinbindungsprotein und dessen Herstellung.
AUPN154295A0 (en) Nucleic acid molecule encoding a protein with avian gamma-interferon activity
EP0369816A3 (en) Monoclonal antibodies specific for human polymorphic epithelial mucin
DK38889A (da) Onkogen-indkodet polypeptid med vaekstfaktoraktivitet
AU669149B2 (en) Expression signal-peptide-free staphylokinases
WO2000053733A3 (en) Hermansky pudlak syndrome protein-interacting proteins and methods of use thereof
ATE230027T1 (de) Menschliche dnase i varianten
WO1996027015A3 (en) A novel gene for a protein kinase associated with drug resistance
ES2311472T3 (es) Nuevos genes de control del ciclo celular y proteinas codificadas por los mismos.
WO2004042043A3 (en) Crystal structures of bacterial ribulose-phosphate 3-epimerases
WO2004013167A3 (en) Purified polypeptides from enterococcus faecalis
WO2001068693A8 (fr) Nouveau polypeptide, proteine humaine de reception cannabinoide 7, et polynucleotide codant pour ce polypeptide
WO2004058811A3 (en) Crystal structures of yhhf polypeptides
WO2003087352A3 (en) Enolase polypeptides and structures

Legal Events

Date Code Title Description
FD5 Application fees: dismissal - article 86 of industrial property law